NewcelX Ltd.
(NASDAQ: NCEL)
NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquarter in Kloten, Switzerland.
3.645
+0.035
(+0.97%)
Range
3.510 - 3.684
(4.96%)
Open
3.620
Previous Close
3.610
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
28,360
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 04:05.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
